New review ranks biologics and small molecules in treatment of moderate-to-severe UC

The choice of biologics and oral small molecule drugs for treatment of ulcerative colitis may be informed by the latest results indirect comparisons, the authors of a new review say. In the absence of head to head trials for many agents, decisions on the selection and positioning of therapy may be helped by findings from ...

Already a member?

Login to keep reading.

© 2022 the limbic